BIOPHTA
PrivateLast Round
Seed
Jun 3, 2024
Total Funding Raised
$7.84M
Momentum Score
25 /100
Company Overview
BIOPHTA is a preclinical-stage biotech company developing a technology for the treatment of eye diseases. Its ophthalmic insert technology is a mini-tablet that transforms into a hydrogel on the eye's surface, providing a continuous, controlled low dose of a drug for seven days.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOPHTA Comps
Public and private peers based on sector, stage, and business model.
BIOPHTA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2024 | ||||
| Pre Seed | May 20, 2021 | ||||
| Accelerator | Oct 18, 2020 |
Key People
Founding team and executive leadership
BIOPHTA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GO Capital | Seed |
| Sofimac Investment Managers | Seed |
| Mérieux Equity Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 110% MoM, reaching 1.1K.
- Jan 22, 2025
Grew 60% QoQ from 5 to 8 employees.
BIOPHTA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BIOPHTA's valuation, stock price, and market status.
